Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study. - Labrie, Fernand; Archer, David F.; Bouchard, Céline; Girard, Ginette; Ayotte, Normand; Gallagher, John C.; Cusan, Leonello; Baron, Mira; Blouin, François; Waldbaum, Arthur S.; Koltun, William; Portman, David J.; et al. (Maturitas, 2015)